Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Recommendations for Remote Robotic Assisted Surgery From the CRSA 2025 International Consensus Conference.

World journal of surgery·2026
Same author

Gold Nanoparticles-Embedded Mn/Zn-MOF with Enhanced Antioxidant Activities for Treating Atopic Dermatitis.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Full-length transcriptomic profiling reveals age-associated isoform remodeling and altered coding potential in the mouse ovary.

Journal of ovarian research·2026
Same author

Proteolytic-derived antimicrobial peptides from Lactiplantibacillus plantarum: From mechanism to application in fermented foods.

Food chemistry·2026
Same author

Robotic versus Open Pancreatoduodenectomy (PORTAL): multicentre, single masked, phase 3, non-inferiority randomised controlled trial.

BMJ (Clinical research ed.)·2026
Same author

Cross-Category Screening of Food Samples for Amyloid-β42 Aggregation-Inhibitory Activity Using a Microliter-Scale High-Throughput Screening System with Quantum-Dot-Labeled Aβ.

Foods (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 9, 2025

Characterization of Amyloid Structures in Aging C. Elegans Using Fluorescence Lifetime Imaging
09:31

Characterization of Amyloid Structures in Aging C. Elegans Using Fluorescence Lifetime Imaging

Published on: March 27, 2020

7.0K

Analyzing Amylin Aggregation Inhibition Through Quantum Dot Fluorescence Imaging.

Xiaoyu Yin1, Ziwei Liu1, Gegentuya Huanood1

  • 1Graduate School of Engineering, Muroran Institute of Technology, Muroran 050-8585, Japan.

International Journal of Molecular Sciences
|October 26, 2024
PubMed
Summary

Researchers used quantum dot imaging to study amylin aggregation, a key factor in type 2 diabetes. They identified rosmarinic acid as a potential inhibitor of this protein misfolding process.

Keywords:
amylinamylin aggregation inhibitoramylin fibrilsquantum dot

More Related Videos

Quantitative Cell Biology of Neurodegeneration in Drosophila Through Unbiased Analysis of Fluorescently Tagged Proteins Using ImageJ
08:44

Quantitative Cell Biology of Neurodegeneration in Drosophila Through Unbiased Analysis of Fluorescently Tagged Proteins Using ImageJ

Published on: August 3, 2018

9.9K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.2K

Related Experiment Videos

Last Updated: Jun 9, 2025

Characterization of Amyloid Structures in Aging C. Elegans Using Fluorescence Lifetime Imaging
09:31

Characterization of Amyloid Structures in Aging C. Elegans Using Fluorescence Lifetime Imaging

Published on: March 27, 2020

7.0K
Quantitative Cell Biology of Neurodegeneration in Drosophila Through Unbiased Analysis of Fluorescently Tagged Proteins Using ImageJ
08:44

Quantitative Cell Biology of Neurodegeneration in Drosophila Through Unbiased Analysis of Fluorescently Tagged Proteins Using ImageJ

Published on: August 3, 2018

9.9K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.2K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Disease Pathogenesis

Background:

  • Protein misfolding and aggregation are implicated in various diseases.
  • Amylin deposition is a hallmark of type 2 diabetes, yet its aggregation mechanism remains poorly understood.
  • Understanding amylin aggregation is crucial for developing effective type 2 diabetes treatments.

Purpose of the Study:

  • To investigate the aggregation process of amylin using quantum dot (QD) imaging.
  • To characterize the morphology and deposition of amylin aggregates.
  • To screen for compounds that inhibit amylin aggregation.

Main Methods:

  • Quantum dot (QD) fluorescence imaging to monitor amylin aggregation over time.
  • Confocal laser microscopy to observe three-dimensional aggregate deposition.
  • Transmission electron microscopy (TEM) to analyze the structure of amylin fibrils.
  • Microliter-scale high-throughput screening (MSHTS) to evaluate inhibitory compounds.

Main Results:

  • QD imaging showed dose- and time-dependent amylin aggregation, with significant aggregate formation observed after 24 hours.
  • TEM confirmed amylin exists as misfolded fibrils in vitro, with QDs binding uniformly.
  • Confocal microscopy revealed three-dimensional deposition of amylin aggregates.
  • Rosmarinic acid, a polyphenol, was identified as an inhibitor of amylin aggregation with a half-maximal effective concentration (EC50) of 852.8 μM.

Conclusions:

  • The study elucidates key aspects of the amylin aggregation process.
  • The MSHTS system is validated as an effective tool for assessing amylin aggregation inhibitors.
  • Findings contribute to understanding type 2 diabetes pathogenesis and offer potential therapeutic strategies.